These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15923115)

  • 41. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
    Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R
    ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality.
    Lu D; Vince R
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5614-9. PubMed ID: 17822899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
    Ali A; Reddy GS; Cao H; Anjum SG; Nalam MN; Schiffer CA; Rana TM
    J Med Chem; 2006 Dec; 49(25):7342-56. PubMed ID: 17149864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.
    Thaisrivongs S; Skulnick HI; Turner SR; Strohbach JW; Tommasi RA; Johnson PD; Aristoff PA; Judge TM; Gammill RB; Morris JK; Romines KR; Chrusciel RA; Hinshaw RR; Chong KT; Tarpley WG; Poppe SM; Slade DE; Lynn JC; Horng MM; Tomich PK; Seest EP; Dolak LA; Howe WJ; Howard GM; Watenpaugh KD
    J Med Chem; 1996 Oct; 39(22):4349-53. PubMed ID: 8893827
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of N-methylpiperazine for the preparation of piperazine-based unsymmetrical bis-ureas as anti-HIV agents.
    El-Faham A; Armand-Ugón M; Esté JA; Albericio F
    ChemMedChem; 2008 Jul; 3(7):1034-7. PubMed ID: 18383064
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases.
    Wei Y; Ma CM; Hattori M
    Bioorg Med Chem; 2009 Apr; 17(8):3003-10. PubMed ID: 19339186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).
    Lin Y; Liu X; Yan R; Li J; Pannecouque C; Witvrouw M; De Clercq E
    Bioorg Med Chem; 2008 Jan; 16(1):157-63. PubMed ID: 17964796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: anti-HIV agents.
    Rawal RK; Tripathi R; Kulkarni S; Paranjape R; Katti SB; Pannecouque C; De Clercq E
    Chem Biol Drug Des; 2008 Aug; 72(2):147-54. PubMed ID: 18624810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
    Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New, potent P1/P2-morpholinone-based HIV-protease inhibitors.
    Kazmierski WM; Furfine E; Spaltenstein A; Wright LL
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5226-30. PubMed ID: 16904316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development.
    François KO; Auwerx J; Schols D; Balzarini J
    Mol Pharmacol; 2008 Aug; 74(2):330-7. PubMed ID: 18474667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors.
    Jones KL; Holloway MK; Su HP; Carroll SS; Burlein C; Touch S; DiStefano DJ; Sanchez RI; Williams TM; Vacca JP; Coburn CA
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4065-8. PubMed ID: 20547452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of novel isopropanolamine derivatives as non-peptide human immunodeficiency virus protease inhibitors.
    Zhou L; Yang Q; Wang Y; Hu Y; Luo X; Bai D; Li S
    Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1147-52. PubMed ID: 18670116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and in vitro biological evaluation of mannose-containing prodrugs derived from clinically used HIV-protease inhibitors with improved transepithelial transport.
    Roche D; Greiner J; Aubertin AM; Vierling P
    Bioconjug Chem; 2006; 17(6):1568-81. PubMed ID: 17105238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Zhan P; Liu X; Cao Y; Wang Y; Pannecouque C; De Clercq E
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5368-71. PubMed ID: 18824350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors.
    Brik A; Alexandratos J; Lin YC; Elder JH; Olson AJ; Wlodawer A; Goodsell DS; Wong CH
    Chembiochem; 2005 Jul; 6(7):1167-9. PubMed ID: 15934050
    [No Abstract]   [Full Text] [Related]  

  • 57. Topological models for the prediction of HIV-protease inhibitory activity of tetrahydropyrimidin-2-ones.
    Lather V; Madan AK
    J Mol Graph Model; 2005 Jan; 23(4):339-45. PubMed ID: 15670954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea--synthesis and structure-activity relationships.
    Sham HL; Betebenner DA; Rosenbrook W; Herrin T; Saldivar A; Vasavanonda S; Plattner JJ; Norbeck DW
    Bioorg Med Chem Lett; 2004 May; 14(10):2643-5. PubMed ID: 15109669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters.
    Hagen SE; Domagala J; Gajda C; Lovdahl M; Tait BD; Wise E; Holler T; Hupe D; Nouhan C; Urumov A; Zeikus G; Zeikus E; Lunney EA; Pavlovsky A; Gracheck SJ; Saunders J; VanderRoest S; Brodfuehrer J
    J Med Chem; 2001 Jul; 44(14):2319-32. PubMed ID: 11428926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold.
    Ekegren JK; Unge T; Safa MZ; Wallberg H; Samuelsson B; Hallberg A
    J Med Chem; 2005 Dec; 48(25):8098-102. PubMed ID: 16335934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.